KR900014422A - 신규 스테로이드 디올과 이들을 함유하는 약제학적 조성물 및 이들의 제조방법 - Google Patents
신규 스테로이드 디올과 이들을 함유하는 약제학적 조성물 및 이들의 제조방법 Download PDFInfo
- Publication number
- KR900014422A KR900014422A KR1019900003056A KR900003056A KR900014422A KR 900014422 A KR900014422 A KR 900014422A KR 1019900003056 A KR1019900003056 A KR 1019900003056A KR 900003056 A KR900003056 A KR 900003056A KR 900014422 A KR900014422 A KR 900014422A
- Authority
- KR
- South Korea
- Prior art keywords
- hydrogen
- general formula
- dione
- dihydroxypregnan
- acetate
- Prior art date
Links
- -1 steroid diols Chemical class 0.000 title claims 6
- 238000000034 method Methods 0.000 title claims 5
- 239000008194 pharmaceutical composition Substances 0.000 title claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 9
- 239000001257 hydrogen Substances 0.000 claims 9
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 9
- 238000004519 manufacturing process Methods 0.000 claims 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 4
- 229910052783 alkali metal Inorganic materials 0.000 claims 4
- 238000007254 oxidation reaction Methods 0.000 claims 4
- 150000001340 alkali metals Chemical class 0.000 claims 3
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims 3
- 239000012266 salt solution Substances 0.000 claims 3
- 239000002904 solvent Substances 0.000 claims 3
- SSRRNSIFGYPVCZ-NXONNOOXSA-N (8R,9S,10S,13R,14S,17S)-17-ethyl-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,16,17-tetradecahydrocyclopenta[a]phenanthrene-15,15-diol Chemical class C1CC2CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C(O)(O)C[C@H](CC)[C@@]1(C)CC2 SSRRNSIFGYPVCZ-NXONNOOXSA-N 0.000 claims 2
- 229960000583 acetic acid Drugs 0.000 claims 2
- 125000002252 acyl group Chemical group 0.000 claims 2
- 150000001342 alkaline earth metals Chemical class 0.000 claims 2
- 230000003110 anti-inflammatory effect Effects 0.000 claims 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- 239000012362 glacial acetic acid Substances 0.000 claims 2
- 229910052736 halogen Chemical group 0.000 claims 2
- 150000002367 halogens Chemical group 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 230000003204 osmotic effect Effects 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 230000007062 hydrolysis Effects 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- LBSANEJBGMCTBH-UHFFFAOYSA-N manganate Chemical compound [O-][Mn]([O-])(=O)=O LBSANEJBGMCTBH-UHFFFAOYSA-N 0.000 claims 1
- 239000012286 potassium permanganate Substances 0.000 claims 1
- 150000003126 pregnane derivatives Chemical class 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0092—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by an OH group free esterified or etherified
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (10)
- 일반식(Ⅰ)의 신규 △14-16α, 17-디히드록시프레그난 유도체.일반식(Ⅰ)상기식 중, A는 수소, 히드록시 또는 트리플루오로아세톡시기 이고, R은 수소, 벤조일 또는 C1-8알카노일기이며,은 인접한 두 개의 탄소원자간의 단일결합 또는 이중 결합이고, X는 수소 또는 할로겐이며, A가 수소이면 X도 수소이다.
- 11β,16α,17,21-테트라히드록시프레그나-4,14-디엔-3,20-디온-21-아세테이트; 11β,16α,17,21-테트라히드록시프레그나-1,4,14-트리엔-3,20-디온-21-아세테이트; 16α,17,21-트리히드록시프레그나-4,14-디엔-3,20-디온-21-아세테이트; 16α,17,21-트리히드록시프레그나-4,14-디엔-3,20-디온-16α,17,21-21-트리히드록시 프레그나-1,4,14-트리엔-3,20-디온-아세테이트; 9α-플루오로-11β,16α,17,21-테트라히드록시프레그나-1,4,14-트리엔-3,20-디온-11-트리플루오로아세테이트-21-아세테이트; 11β,16α,17,21-테트라히드록시프레그나-1,4,14-트리엔-3,20-디온-11-벤조에이트중의 한 화합물.
- 상기 제1항의 일반식(Ⅰ)의 △14-16α,17-디히드록시프레그난 유도체 중 하나나 둘 이상을 제약업에서 일반적으로 사용되는 부형제, pH조절체, 삼투압조절체,희석제,안정화제, 담체 중 하나나 둘 이상과 혼합하여 된 항염성 약제학적 조성물.
- 일반식(2)의 프레그난 유도체를 물 또는 아세톤 하에서 C2-4알카노익산을 용매로하여 알칼리 금속 과산화망 간염 또는 알카리 토금속 과산화망간염으로써 산화시키거나 필요한 경우 일반식(2)의 산화물을 가수분해 시킴을 특징으로 하는 상기 제1항의 일반식 △14-16α,17-디히드록시프레그난 유도체의 제조방법.일반식(2)상기 식 중, A는 수소, 히드록시 또는 트리플루오로아세톡시기 이고, R은 벤조일 또는 C1-3알카노일기이며,은 인접한 두개의 탄소원자간의 단일결합 또는 이중 결합이고,X는 수소 또는 할로겐이며, A가 수소이면 X도 수소이다.
- 제4항에 있어서, 상기 산화반응이 빙초산을 용매로하여 알카리 금속 과망간산염의 수용액 또는 알카리 토금속 과망간산염의 수용액을 사용하는 것을 특징으로 하는 상기 제1항의 일반식(1)의 △14-16α,17-디히드록시프레그난 유도체의 제조방법.
- 제4항에 있어서, 상기 산화반응이 빙초산과 아세톤을 혼합한 것을 용매로 하여 알카리금속 과망간산염의 수용액 또는 알카리 토금속 과망간산염의 수용액을 사용하는 것을 특징으로 하는 상기 제1항의 일반식 △14-16α,17-디히드록시프레그난 유도체의 제조방법.
- 제4항 내지 제6항중 어느 한 항에 있어서, 알카리금속과 망간산염이 과망간산 칼륨인 것을 특징으로 하는 상기 제1항의 일반식 (1)의 △14-16α,17-디히드록시프레그난 유도체의 제조방법.
- 제5항에 있어서, 상기 산화반응을 0°내지 20℃의 온도에서 실시하는 것을 특징으로 하는 상기 제1항의 일반식(1)의 △14-16α,17-디히드록시프레그난 유도체의 제조방법.
- 제6항에 있어서, 상기 산화반응을 -10℃ 내지 -30℃의 온도에서 실시하는 것을 특징으로 하는 상기 제1항이 일반식(1)의 △14-16α,17-디히드록시프레그난 유도체의 제조방법.
- 활성성분인 상기 제1항의 일반식(1)의 신규 △14-16α,17-디히드록시프레그난 유도체 중 하나나 둘 이상을 제약업에서 일반적으로 사용되는 부형제, pH조절제, 삼투압 조절제, 희석제, 안정화제, 담체 중 하나나 둘 이상과 혼합하고, 상기 혼합물을 약제학적 조성물로 변환시킴을 특징으로 하는 항염성 약제학적 조성물의 제조방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU891156A HU203562B (en) | 1989-03-09 | 1989-03-09 | Process for producing new steroide diols and pharmaceutical compositions containing them |
HU1156/89 | 1989-03-09 | ||
HU6602.89 | 1989-03-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR900014422A true KR900014422A (ko) | 1990-10-23 |
KR930009445B1 KR930009445B1 (ko) | 1993-10-04 |
Family
ID=10953088
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019900003056A KR930009445B1 (ko) | 1989-03-09 | 1990-03-08 | 신규 스테로이드 디올과 이들을 함유하는 약제학적 조성물 및 이들의 제조방법 |
Country Status (17)
Country | Link |
---|---|
US (1) | US5082835A (ko) |
EP (1) | EP0387091A3 (ko) |
JP (1) | JPH06104679B2 (ko) |
KR (1) | KR930009445B1 (ko) |
CN (1) | CN1045396A (ko) |
AR (1) | AR244700A1 (ko) |
AU (1) | AU623503B2 (ko) |
CA (1) | CA2011282A1 (ko) |
EG (1) | EG19411A (ko) |
FI (1) | FI901199A0 (ko) |
HU (1) | HU203562B (ko) |
IL (1) | IL93478A (ko) |
IN (1) | IN170846B (ko) |
NO (1) | NO177147C (ko) |
PH (1) | PH26676A (ko) |
PT (1) | PT93375A (ko) |
ZA (1) | ZA901752B (ko) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9100341D0 (sv) * | 1991-02-04 | 1991-02-04 | Astra Ab | Novel steroids |
FR2675146A1 (fr) * | 1991-04-10 | 1992-10-16 | Roussel Uclaf | Nouveaux derives sterouides de la pregna-1,4-diene-3,20-dione, leur preparation, leur application a la preparation de derives 16,17-methylene dioxy substitues et nouveaux intermediaires. |
ES2347027T3 (es) | 1998-05-22 | 2010-10-22 | The Board Of Trustees Of The Leland Stanford Junior University | Moleculas bifuncionales y terapias basadas en las mismas. |
EP3827747A1 (en) | 2005-04-28 | 2021-06-02 | Otsuka Pharmaceutical Co., Ltd. | Pharma-informatics system |
EP1945240B1 (en) | 2005-09-16 | 2016-12-28 | Raptor Pharmaceutical Inc | Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof |
HUE059078T2 (hu) | 2009-02-20 | 2022-10-28 | Enhanx Biopharm Inc | Glutation-alapú hatóanyagszállító rendszer |
IL295075A (en) | 2009-05-06 | 2022-09-01 | Laboratory Skin Care Inc | Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them |
CN110078785A (zh) * | 2019-06-04 | 2019-08-02 | 博诺康源(北京)药业科技有限公司 | 一种布地奈德杂质ep-ze的合成方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3167545A (en) * | 1959-02-07 | 1965-01-26 | Syntex Corp | 16beta-methyl-16alpha, 17 alpha-dihydroxy pregnenes and the 16alpha, 17alpha-cyclic ketals and acetals thereof |
US3345362A (en) * | 1961-07-27 | 1967-10-03 | Lilly Co Eli | Novel pregnenolone acetonides |
US4036831A (en) * | 1975-10-28 | 1977-07-19 | Steroid Development Company Establishment | Trimethyl siloxane steroid intermediates |
JP2604842B2 (ja) * | 1987-08-14 | 1997-04-30 | ジ・アップジョン・カンパニー | 改良された9α‐脱ハロゲン化方法 |
-
1989
- 1989-03-09 HU HU891156A patent/HU203562B/hu not_active IP Right Cessation
-
1990
- 1990-02-21 IL IL9347890A patent/IL93478A/en not_active IP Right Cessation
- 1990-02-28 IN IN185/CAL/90A patent/IN170846B/en unknown
- 1990-03-01 CA CA002011282A patent/CA2011282A1/en not_active Abandoned
- 1990-03-05 PH PH40143A patent/PH26676A/en unknown
- 1990-03-07 ZA ZA901752A patent/ZA901752B/xx unknown
- 1990-03-08 JP JP2055162A patent/JPH06104679B2/ja not_active Expired - Lifetime
- 1990-03-08 NO NO901103A patent/NO177147C/no unknown
- 1990-03-08 AU AU51102/90A patent/AU623503B2/en not_active Ceased
- 1990-03-08 KR KR1019900003056A patent/KR930009445B1/ko not_active IP Right Cessation
- 1990-03-08 PT PT93375A patent/PT93375A/pt not_active Application Discontinuation
- 1990-03-09 FI FI901199A patent/FI901199A0/fi not_active IP Right Cessation
- 1990-03-09 CN CN90101248A patent/CN1045396A/zh active Pending
- 1990-03-09 AR AR90316352A patent/AR244700A1/es active
- 1990-03-09 EP EP19900302544 patent/EP0387091A3/en not_active Ceased
- 1990-03-09 US US07/491,683 patent/US5082835A/en not_active Expired - Fee Related
- 1990-03-11 EG EG16090A patent/EG19411A/xx active
Also Published As
Publication number | Publication date |
---|---|
ZA901752B (en) | 1991-05-29 |
JPH02279695A (ja) | 1990-11-15 |
CA2011282A1 (en) | 1990-09-09 |
IL93478A (en) | 1994-11-11 |
AU5110290A (en) | 1990-09-13 |
EG19411A (en) | 1995-01-31 |
EP0387091A3 (en) | 1992-05-06 |
IN170846B (ko) | 1992-05-30 |
JPH06104679B2 (ja) | 1994-12-21 |
NO901103L (no) | 1990-09-10 |
AU623503B2 (en) | 1992-05-14 |
AR244700A1 (es) | 1993-11-30 |
FI901199A0 (fi) | 1990-03-09 |
NO177147C (no) | 1995-07-26 |
EP0387091A2 (en) | 1990-09-12 |
NO177147B (no) | 1995-04-18 |
IL93478A0 (en) | 1990-11-29 |
PH26676A (en) | 1992-09-15 |
CN1045396A (zh) | 1990-09-19 |
NO901103D0 (no) | 1990-03-08 |
HU203562B (en) | 1991-08-28 |
US5082835A (en) | 1992-01-21 |
PT93375A (pt) | 1990-11-07 |
KR930009445B1 (ko) | 1993-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR900014422A (ko) | 신규 스테로이드 디올과 이들을 함유하는 약제학적 조성물 및 이들의 제조방법 | |
JPS596880B2 (ja) | D−ホモステロイドの製造方法 | |
US3839369A (en) | Process for the production of delta4,9(11),16-3,20-diketo steroids | |
US3842105A (en) | Process for the preparation of 16,17-unsaturated steroids | |
US4270994A (en) | Electrochemical dehydrogenation of steroidal Δ3,5 enol ethers under basic conditions to provide steroidal Δ4,6 dienones | |
US3485852A (en) | 6-halo-6-dehydro-progesterones | |
US3349083A (en) | Process for the production of 6beta:19-oxido-steroids | |
US2509248A (en) | Process for producing delta9, 11-3(alpha)-hydroxy-17-ketoetiocholene | |
ES546995A0 (es) | Procedimiento para la preparacion de derivados de pregnano | |
GB1472922A (en) | Pregnanoic acid derivatives | |
GB1060793A (en) | Improvements in or relating to steroids and the manufacture thereof | |
DE2614079C2 (de) | D-Homosteroide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate | |
US4033995A (en) | D-homo steroids | |
US3493588A (en) | Process for the preparation of 6-chloro-16-methylene - 17alpha - lower alkanoyloxy-4,6-pregnadiene-3,20-dione and novel intermediates produced thereby | |
US3718670A (en) | Process for the preparation of 17-oxo-steroids from 17a-hydroxy-20-oxo-steroids | |
US2889346A (en) | Method of making 15alpha hydroxy desoxycorticosterone and intermediates employed therefor | |
US3396161A (en) | Process for the manufacture of 6alpha, 9alpha-difluoro-1, 4-pregnadiene-3, 20-diones | |
US4008313A (en) | Novel corticoids | |
KR800000407B1 (ko) | D-호모스테로이드의 제조방법 | |
DE1131213B (de) | Verfahren zur Herstellung neuer Pregnanverbindungen | |
US2973374A (en) | Process for the production of delta4-19-norpregnene-21-ol-3, 11, 20-triones | |
US3098085A (en) | Process for the manufacture of 16alpha-methyl-allopregnanes substituted in the 21-position | |
DE1593505C3 (ko) | ||
US3081299A (en) | Novel 5, 9-cyclo-1, 11-oxidosteroids and methods for their manufacture | |
AT242870B (de) | Verfahren zur Herstellung von neuen ungesättigten fluorhaltigen Steroiden |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |